Yang Mei, Huang Yasheng, Gao Feng, He Liping, Yu Xueyao, Yu Qiqi
Department of Nursing, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.
Department of Urology, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China.
Ther Adv Urol. 2024 Sep 20;16:17562872241281578. doi: 10.1177/17562872241281578. eCollection 2024 Jan-Dec.
To systematically identify and quantify the incidence and risk factors of postoperative urinary incontinence (UI) in holmium laser enucleation of the prostate (HoLEP), aiming to provide a basis for intervention strategies.
Relevant studies on postoperative UI in HoLEP were searched in databases including PubMed, Web of Science, EMBase, CNKI, Wanfang Data Knowledge Service Platform, VIP and CBMdisc, with the search period up to April 2024. Titles, abstracts and full texts were screened using the Endnote application. Studies meeting the inclusion and exclusion criteria underwent quality assessment and data extraction. The incidence of postoperative UI and/or adjusted or unadjusted odds ratios (OR), relative risks or ratios were recorded, and analysis was conducted using Stata 15.0 software.
A total of 17 studies encompassing 7939 patients were included. The pooled incidence of UI after HoLEP was 1.12, 95% CI (1.11-1.13); the 3-month postoperative incidence was 1.06, 95% CI (1.05-1.06); the 6-month postoperative incidence was 1.04, 95% CI (1.03-1.05); the 12-month postoperative incidence was 1.05, 95% CI (1.03-1.06); and the incidence of permanent UI after HoLEP was 1.01, 95% CI (1.00-1.01). The occurrence of UI after HoLEP exhibited a time-dependent variation. The risk factors for UI after HoLEP included the following: age (OR = 1.03, 95% CI: 1.01-1.06); body mass index (BMI; OR = 1.10, 95% CI: 1.01-1.20); prostate volume (OR = 1.77, 95% CI: 1.39-2.27); prostate-specific antigen (PSA) (OR = 0.98, 95% CI: 0.87-0.92); International Prostate Symptom Score (IPSS) (OR = 0.94, 95% CI: 0.83-1.07).
The results of this study indicate a decreasing trend in the incidence of postoperative UI after HoLEP over time, with a time-dependent change. Age, BMI, prostate volume, PSA and IPSS are risk factors for postoperative UI after HoLEP. Age and prostate volume have a significant impact on UI. Therefore, preoperative assessment and intervention for these factors are crucial in reducing the occurrence of postoperative UI in HoLEP.
系统识别并量化钬激光前列腺剜除术(HoLEP)后尿失禁(UI)的发生率及危险因素,旨在为干预策略提供依据。
在PubMed、Web of Science、EMBase、中国知网、万方数据知识服务平台、维普和中国生物医学文献数据库等数据库中检索HoLEP术后UI的相关研究,检索期限截至2024年4月。使用Endnote应用程序筛选标题、摘要和全文。对符合纳入和排除标准的研究进行质量评估和数据提取。记录术后UI的发生率和/或调整或未调整的比值比(OR)、相对风险或比率,并使用Stata 15.0软件进行分析。
共纳入17项研究,涉及7939例患者。HoLEP术后UI的合并发生率为1.12,95%置信区间(CI)(1.11 - 1.13);术后3个月发生率为1.06,95%CI(1.05 - 1.06);术后6个月发生率为1.04,95%CI(1.03 - 1.05);术后12个月发生率为1.05,95%CI(1.03 - 1.06);HoLEP后永久性UI的发生率为1.01,95%CI(1.00 - 1.01)。HoLEP后UI的发生呈现时间依赖性变化。HoLEP后UI的危险因素包括:年龄(OR = 1.03,95%CI:1.01 - 1.06);体重指数(BMI;OR = 1.10,95%CI:1.01 - 1.20);前列腺体积(OR = 1.77,95%CI:1.39 - 2.27);前列腺特异性抗原(PSA)(OR = 0.98,95%CI:0.87 - 0.92);国际前列腺症状评分(IPSS)(OR = 0.94,95%CI:0.83 - 1.07)。
本研究结果表明,HoLEP术后UI的发生率随时间呈下降趋势,具有时间依赖性变化。年龄、BMI、前列腺体积、PSA和IPSS是HoLEP术后UI的危险因素。年龄和前列腺体积对UI有显著影响。因此,术前对这些因素进行评估和干预对于降低HoLEP术后UI的发生至关重要。